{'fraction_non_alphanumeric': 0.026917900403768506, 'fraction_numerical': 0.0026917900403768506, 'mean_word_length': 5.413793103448276, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Colorectal polyposis: clinical presentation and surgical treatment

Conditions that increase the risk of CRC include age, a personal and family history of colorectal cancer (CRC) and chronic inflammatory bowel disease, but the main prerequisite for developing cancer is the presence of adenoma [1]. The risk of malignancy in an adenoma depends on its size, grade of dysplasia and number present [2]. Conditions characterised by multiple adenomas are therefore at high risk of developing carcinoma of the large bowel. The most common polyposis disorders include familial adenomatous polyposis (FAP) and the multiple colorectal adenomas (MCRAs) syndromes. This article aims to review the clinical, genetic and treatment aspects of FAP and MCRAs.